Savara is pleased to partner with The Balancing Act to highlight autoimmune pulmonary alveolar proteinosis (aPAP), a rare respiratory disease with no currently approved medicines in the United States or Europe. Educating people about the hallmark signs and symptoms of aPAP, as well as the simple, accurate, non-invasive blood test to help diagnose the disease, may increase awareness for this debilitating condition and provide a quicker path to diagnosis for patients. For additional information, please visit https://lnkd.in/enwPBsnK
While facing a life-threatening hospital stay, Eric's family and friends started doing research. They found Dr. Trapnell, who suggested a noninvasive blood test to confirm Eric's diagnosis of aPAP. Armed with an accurate diagnosis, Eric was quickly able to begin working with his Pulmonologist on managing this rare disease. Watch the full story on TheBalancingAct.com/rare. Visit Savara Inc. to learn more. #BehindTheMystery #aPAP #AutoimmunePulmonaryAlveolarProteinosis #aPAPawareness #RareDisease #RareDiseaseAwareness